This inventor holds 4 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignee: Council of Scientific and Industrial Research. Active years: 2022-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022-2025
Title: Innovations of Srihari Pabbaraja
Introduction
Srihari Pabbaraja is a notable inventor based in Telangana, India. He has made significant contributions to the field of chemistry, particularly in the development of novel compounds and processes. With a total of 4 patents to his name, his work has implications in various applications, including pharmaceuticals.
Latest Patents
One of his latest patents is titled "Indole-ynone mediated benzoannulation process for the preparation of carbazoles." This invention relates to carbazoles of general formula (I) and outlines a process for their preparation. The compounds produced can have various substituents, including H, C1-C6 alkyl, and phenyl groups. Another significant patent is the "Chemo-enzymatic process for the preparation of homopropargylic alcohol." This invention describes an enzymatic process for the preparation of optically pure enantiomers of homopropargylic alcohol compounds, which are useful intermediates for synthesizing Halichondrin B and its analogs.
Career Highlights
Srihari Pabbaraja is affiliated with the Council of Scientific and Industrial Research, where he conducts research and development in his field. His innovative approaches and dedication to scientific inquiry have positioned him as a valuable contributor to the scientific community.
Collaborations
He has collaborated with notable colleagues, including Ajay Kumar Singh and Subhash Ghosh, to further advance research initiatives and explore new avenues in chemical innovation.
Conclusion
Srihari Pabbaraja's work exemplifies the spirit of innovation in the field of chemistry. His patents not only contribute to scientific knowledge but also pave the way for future advancements in pharmaceutical applications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
